scispace - formally typeset
Search or ask a question
Journal ArticleDOI

Rayyan-a web and mobile app for systematic reviews.

TL;DR: The strongest features of the app, identified and reported in user feedback, were its ability to help in screening and collaboration as well as the time savings it affords to users.
Abstract: Synthesis of multiple randomized controlled trials (RCTs) in a systematic review can summarize the effects of individual outcomes and provide numerical answers about the effectiveness of interventions. Filtering of searches is time consuming, and no single method fulfills the principal requirements of speed with accuracy. Automation of systematic reviews is driven by a necessity to expedite the availability of current best evidence for policy and clinical decision-making. We developed Rayyan ( http://rayyan.qcri.org ), a free web and mobile app, that helps expedite the initial screening of abstracts and titles using a process of semi-automation while incorporating a high level of usability. For the beta testing phase, we used two published Cochrane reviews in which included studies had been selected manually. Their searches, with 1030 records and 273 records, were uploaded to Rayyan. Different features of Rayyan were tested using these two reviews. We also conducted a survey of Rayyan’s users and collected feedback through a built-in feature. Pilot testing of Rayyan focused on usability, accuracy against manual methods, and the added value of the prediction feature. The “taster” review (273 records) allowed a quick overview of Rayyan for early comments on usability. The second review (1030 records) required several iterations to identify the previously identified 11 trials. The “suggestions” and “hints,” based on the “prediction model,” appeared as testing progressed beyond five included studies. Post rollout user experiences and a reflexive response by the developers enabled real-time modifications and improvements. The survey respondents reported 40% average time savings when using Rayyan compared to others tools, with 34% of the respondents reporting more than 50% time savings. In addition, around 75% of the respondents mentioned that screening and labeling studies as well as collaborating on reviews to be the two most important features of Rayyan. As of November 2016, Rayyan users exceed 2000 from over 60 countries conducting hundreds of reviews totaling more than 1.6M citations. Feedback from users, obtained mostly through the app web site and a recent survey, has highlighted the ease in exploration of searches, the time saved, and simplicity in sharing and comparing include-exclude decisions. The strongest features of the app, identified and reported in user feedback, were its ability to help in screening and collaboration as well as the time savings it affords to users. Rayyan is responsive and intuitive in use with significant potential to lighten the load of reviewers.

Content maybe subject to copyright    Report

Ouzzani et al. Systematic Reviews
(2016) 5:210
DOI 10.1186/s13643-016-0384-4
METHODOLOGY Open Access
Rayyan—a web and mobile app for
systematic reviews
Mourad Ouzzani
1*
, Hossam Hammady
1
, Zbys Fedorowicz
2
and Ahmed Elmagarmid
1
Abstract
Background: Synthesis of multiple randomized controlled trials (RCTs) in a systematic review can summarize the
effects of individual outcomes and provide numerical answers about the effectiveness of interventions. Filtering of
searches is time consuming, and no single method fulfills the principal requirements of speed with accuracy.
Automation of systematic reviews is driven by a necessity to expedite the availability of current best evidence for
policy and clinical decision-making.
We developed Rayyan (http://rayyan.qcri.org), a free web and mobile app, that helps expedite the initial screening of
abstracts and titles using a process of semi-automation while incorporating a high level of usability. For the beta
testing phase, we used two published Cochrane reviews in which included studies had been selected manually.
Their searches, with 1030 records and 273 records, were uploaded to Rayyan. Different features of Rayyan were tested
using these two reviews. We also conducted a survey of Rayyan’s users and collected feedback through a built-in
feature.
Results: Pilot testing of Rayyan focused on usability, accuracy against manual methods, and the added value of the
prediction feature. The “taster” review (273 records) allowed a quick overview of Rayyan for early comments on
usability. The second review (1030 records) required several iterations to identify the previously identified 11 trials. The
“suggestions” and “hints,” based on the “prediction model,” appeared as testing progressed beyond five included
studies. Post rollout user experiences and a reflexive response by the developers enabled real-time modifications and
improvements. The survey respondents reported 40% average time savings when using Rayyan compared to others
tools, with 34% of the respondents reporting more than 50% time savings. In addition, around 75% of the
respondents mentioned that screening and labeling studies as well as collaborating on reviews to be the two most
important features of Rayyan.
As of November 2016, Rayyan users exceed 2000 from over 60 countries conducting hundreds of reviews totaling
more than 1.6M citations. Feedback from users, obtained mostly through the app web site and a recent survey, has
highlighted the ease in exploration of searches, the time saved, and simplicity in sharing and comparing
include-exclude decisions. The strongest features of the app, identified and reported in user feedback, were its ability
to help in screening and collaboration as well as the time savings it affords to users.
Conclusions: Rayyan is responsive and intuitive in use with significant potential to lighten the load of reviewers.
Keywords: Systematic reviews, Evidence-based medicine, Automation
*Correspondence: mouzzani@qf.org.qa
1
Qatar Computing Research Institute, HBKU, Doha, Qatar
Full list of author information is available at the end of the article
© The Author(s). 2017 Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0
International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the
Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver
(http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.

Ouzzani et al. Systematic Reviews
(2016) 5:210
Page 2 of 10
Background
Randomized controlled trials (RCTs) play a pivotal role in
medical research and are widely considered to be the best
way of achieving results that can genuinely increase our
knowledge about treatment effectiveness [1]. Although
there is an increasing requirement for randomized con-
trolled trials to guide healthcare decision-making, the
synthesis of the results of more than one RCT in a system-
atic review can summarize the effects of their individual
outcomes and provide numerical answers about the effec-
tiveness of a particular intervention.
A systematic review is a summary of the medical liter-
ature that uses explicit methods to systematically search,
critically appraise, and synthesize the data on a specific
topic. The need for rigor in the production of systematic
reviews has led to the development of a formal process for
their conduct. This process has clearly designated steps
to identify primary studies and the methods which will
be employed to assess their methodological quality, the
way in which data will be extracted, and the statistical
techniques that will be used in the synthesis and report-
ing of that data [2]. Transparency and reproducibility are
assured through the documenting of all of the decisions
taken to include or exclude studies throughout the review
process.
Identification of studies: The overarching aim is to
ensure that an exhaustive scrutiny of the literature cre-
ates as comprehensive a list as possible of published and
unpublished primary studies which are deemed relevant
to answering the research question.
The number of citations generated by this search for
eligible studies will depend on a variety of factors not
least of all those involving some of the inherent aspects
of the clinical topic. Thus, a clinical intervention which
has been used extensively over a long period of time may
be underpinned by a large body of research which in
many instances may contain a substantial number of stud-
ies some of which may date back in excess of 20 years.
Other possible contributory factors will include the com-
parative “interest” in the topic by clinicians, healthcare
policy makers, and the media and may even include
the potentially “vested” interest of the pharmaceutical
industry.
Although the initial searches for trials for a systematic
review may in some cases identify up to, and possibly
extend beyond, 1000 citations, this will depend in part on
the level of sensitivity and specificity built into the search
strategy used to search the individual databases. While
it is difficult to generalize what number of references to
studies might be expected in an average yield, a minimum
of 100 would not be an unreasonable number for many
clinical topics.
Identification of potentially eligible studies: One of the
most time consuming aspects of conducting a systematic
review is the preliminary filtering or sifting through the
citations from the searches, particularly if these number
in the several hundreds and possibly in the thousands.
Systematic review authors use a variety of electronic or
manual methods to complete this task, which in any event
must be double-checked by a co-author to ensure that
all potentially eligible studies and those that require fur-
ther full-text assessment have been identified. In addition,
the tracking of decisions to include or exclude stud-
ies and the reporting of these judgments in a PRISMA
flow diagram is mandatory for all Cochrane reviews
and is now being done increasingly in other system-
atic reviews as this becomes a more widely accepted
prerequisite for manuscript publication [3]. Moreover,
the comprehensive documentation of these decisions
by the review authors ensures the transparency, clarity,
and traceability of the selection process and ultimately
reinforces the robustness of the completed systematic
review.
Identification and selection of studies can be challeng-
ing and very tedious, and a number of methods are used
by review authors to facilitate the process. This can be
performed either manually, i.e., by simply “highlighting
them in the printed copy of the search document by the
use of different colors of a text marker, or electronically
using the text highlighting function in the electronic copy
of the search document. Alternative methods include the
use of software such as EndNote or Reference Manager, if
they are available to the review author. No single method
can satisfactorily fulfill all the principal requirements of
speed, accuracy, and simplicity in use, and each has its
advantages, disadvantages, and adherents.
Interest in the automation of systematic reviews has
been driven by a necessity to expedite the availability of
current best evidence for policy and clinical decision-
making as much as engaging with technology to allow
review authors to redirect their focus on aspects where
they are best at [4]. An increasing number of projects are
underway which focus on the automation of segments of
the systematic review process, and although several tools
and software have been developed, so far, none of them
span the entire process of review production [5].
Although the challenges faced by developers to auto-
mate and integrate the multiple steps in the workflow
may seem insurmountable, recent advances in technology
have helped overcome some of these hurdles [6]. However,
accuracy and efficiency should not be sacrificed at the
expense of speed, but flexibility, aligned with the poten-
tial for individual user customizability, should be built into
the tool to allow for a range of users to create and use
different personal preference-based interfaces. Automa-
tion should also target several key areas such as exploring
ways of enhancing the user interface and user experience,
developing systems which will ensure adequate workflow

Ouzzani et al. Systematic Reviews
(2016) 5:210
Page 3 of 10
support, and the fostering of further developments in
machine learning and data/text mining.
The process of automation of systematic reviews con-
tinues to present a number of additional challenges in that
many of the tools have been developed independently as
stand-alone software and are often not compatible with
other tools [5]. In some instances, appropriate reliability
and functionality testing has not been undertaken, and
some tools are no longer being maintained by the devel-
opers or are prohibitively expensive to the average user.
Moreover, some of the tools currently available require
a level of technical skills beyond that of many review
authors and also involve a steep learning curve and level
of complexity which may necessitate a repetitive learn/re-
learn phase if they are not used regularly. All of these
challenges show how unsatisfying the existing landscape
for systematic review automation is. The developers of
Rayyan aim to address these challenges for providing an
integrated solution, by working directly with systematic
reviewers whilst continuously taking into account users’
feedback.
Objectives
Rayyan (http://rayyan.qcri.org) was developed specifically
to expedite the initial screening of abstracts and titles
using a process of semi-automation but with a clear
objective of incorporating a level of usability which would
be compatible with the skillset of a broad cross-section
of potential users. The ab initio objectives of the develop-
ers of the Rayyan app were to try and circumvent some of
the complexities and challenges faced by reviewers with
some of the existing tools. While our ultimate goal is to
support the entire systematic review process, we initially
focus on facilitating abstract/title screening and collabora-
tion in addition to other supporting features around them.
Thus,muchofthefocusofthedevelopmentwasoncreat-
ing an inbuilt user-definable and partly self-customizable
interface which would ensure Rayyan was largely intuitive
in use as well as being user-friendly at all skill levels. We
present here an exceptional case report of the develop-
ment process of Rayyan, an app for the rapid exploring
and filtering of searches for eligible studies for systematic
reviews.
Methods
There was a recognition by the developers of the need for
a tool which would satisfy the requirements of a broad
spectrum of review authors with a diverse range of com-
petencies and skills and specifically one which would
permit rapid and reliable exploration and sharing of search
results but without being technologically burdensome.
Therefore, engagement with an experienced Cochrane
systematic review author (ZF) who had worked exten-
sively with a large number of co-authors with mixed levels
of experience proved to be pivotal to the development
process.
The app underwent pilot testing prior to release and
had extensive subsequent evaluation from a wide range of
users, with a variety of skill levels and competencies, from
across the globe. Sharing of user experiences and a reflex-
ive response by the developers to an evolving “wish list”
of requests by users enabled modifications and improve-
ments to be made progressively and in real time, all of
which proved to be a highly productive and effective
collaboration in the development of Rayyan.
Overview and architecture
Rayyan is built on top of a cloud-based multi-tier service-
oriented elastic architecture (Fig. 1). Scalability in Rayyan
is underpinned by this cloud-based architecture which
allows it to scale accordingly during peak times and as
the number of users grows and they create more reviews
and upload more citations. Moreover, at times, Rayyan
may be actively processing data for tens of users or is
just staying idle. The cloud-based architecture enables it
to expand or shrink its hardware resources as needed. As
a result, it is cost effective in idle times, with no costs
incurred for resources not being used, and at the same
time horizontally scales out in busy times easily. Part of
the resources are only manually scalable, which means
that Rayyan administrators will need to upgrade them as
needed, for example, in increasing database storage needs,
push notifications volume, and email messages volume.
Other resources are automatically scalable to support the
appropriate traffic in a cost-effective manner without sac-
rificing performance. This applies to web servers and
background job workers.
Rayyan itself is written in the popular open-source
framework Ruby on Rails [7], and runs on Heroku [8]
which is a Platform as a Service based on the cloud-
hosting Amazon Web Services. It integrates with other
cloud services to fulfill the different tiers it requires.
Examples of these services are Heroku Postgres [9] for
SQL database management; Logentries [10] for central
logging, tagging, and alerting; NewRelic [11] for app ana-
lytics, health monitoring, and alerting; Pusher [12] for
real-time push notifications; and HireFire [13] for auto-
scaling the app according to load.
Workflow and user experience
After logging into Rayyan, users are presented with a
dashboard of all their current reviews (Fig. 2). They can
either create a new review or work on an existing one.
For each review, they upload one or more citation file
obtained from searching different databases. Rayyan sup-
ports several standard formats, e.g., RefMan RIS and
EndNote. At the outset, Rayyan processes the citation file

Ouzzani et al. Systematic Reviews
(2016) 5:210
Page 4 of 10
Fig. 1 Rayyan architecture. Rayyan is a fully cloud-based architecture that uses a cloud platform as a service allowing elastic scaling of resources as
we get more users and more requests. Rayyan’s workers are distributed using the load balancer to different app servers (Ruby web workers). These
workers are elastic; they auto-scale based on traffic to guarantee minimal response time. For longer jobs or the elastic delayed jobs (the worker
bees), such as upload parsing, similarity computation, and label predictions, they are handled through a queuing system. All workers have access to
the storage layers: Postgres (for permanent storage), Solr (for indexing and searching), and Memcached (for caching results). Other parts of Rayyan,
written in Java, are attachable to the jobs using an Apache Thrift service. Real-time notifications, on job completion or chat messages, for example,
are delivered using Pusher, while other transactional information are delivered using the Mailchimp Mandrill service. All system activities are logged
by Logentries and later backed up on AWS S3, while live instrumentation and monitoring is done by NewRelic
by extracting different metadata, e.g., title, authors, and
computing others, e.g., MeSH terms and language of the
article, for each article or study in the citation file. These
will then populate the facets in the review workbench
(Fig. 3) to help explore and filter the studies. MeSH terms
are presented as a word cloud allowing users to quickly
grasp the main topics presented in the studies. In addi-
tion, users can filter studies based on two predefined lists
of keywords that will most likely hint to either include or
excludeastudy.Theusercanalsomodifythesetwolists
by removing and adding keywords, thus giving more flex-
ibility in the labeling and selection of studies. Rayyan was
seeded with two lists obtained from the EMBASE project
to filter RCTs [14].
Users can also label their citations and define their indi-
vidual reasons for exclusion which facilitates the sharing
and tracking of these decisions. Citations can be explored
through a similarity graph (Fig. 4) in which the citations
are represented as nodes in a graph and clustered based
on how similar they are (using an edit distance) in terms
of title and abstract content as well as common authors.
The similarity thresholds can be tuned independently for
each attribute, i.e., title, abstract, and authors, as well an
overall threshold.
Rayyan mobile app
With the mobile app, users can screen reviews they have
already uploaded from the web app. The most notable fea-
ture is the ability to use the app while offline. Users first
download the entire review while online then work on it
even in the absence of a network connection, and then,
once connected, the app will automatically sync back to
the Rayyan servers.
Predicting included and excluded studies
An important feature of the Rayyan app is its ability to
learn from users’ decisions to include or exclude studies
which can then be used to build a model that would allow

Ouzzani et al. Systematic Reviews
(2016) 5:210
Page 5 of 10
Fig. 2 Rayyan dashboard. The dashboard lists all reviews for this user as well as for each review the progress in terms of decisions made and
estimated time spent working on the review for all collaborators
suggestions to be offered on studies that are awaiting
screening. More specifically, after removing stop words
and stemming the remaining words from the title and
abstract, Rayyan extracts all the words (unigrams) and
pairs of words (bigrams) and previously computed MeSH
terms. These are then used as features by a support vec-
tor machine (SVM) classifier [15]. As users label citations
to studies as excluded or included, Rayyan calls the SVM
classifier which learns the features of these excluded and
included citations and builds a model, or classifier, accord-
ingly. The classifier then runs on the citations that await
labeling and outputs a score of how close each study
matches the include and exclude classes. That score is
then turned into a five-star rating that is presented to
the user. As the user continues to label more citations, if
Rayyan believes it can improve its prediction quality, then
itwillusethesenewlabeledexamplestoproduceanew
model and then run it on the remaining non-labeled cita-
tions. This process is repeated until there are no more
citations to label or the model cannot be improved any
further.
Results and Discussions
Evaluating the prediction algorithm
To test the quality of Rayyans SVM classifier, we used the
abovefeaturesonacollectionofsystematicreviewsfrom
a study published in [16]. In this study, test collections
were built for each of 15 review topics (Table 1) which had
been conducted by the Oregon EPC, Southern California
EPC, and Research Triangle Institute/University of North
Carolina (RTI/UNC) EPC. For each review, we know all
the articles and what was included/excluded. The ratio of
included articles ranged from 0.5 to 21.7%, with the largest
review containing 3465 studies and the smallest 310.
A twofold cross-validation was used with 50% of the
data going to training and 50% to testing. This process
was repeated ten times, and the results were averaged.
Two metrics were used for the evaluation of the quality
of the classifier, AUC and WSS@95. The ROC (receiver
operating characteristic) curve is obtained by graphing
the true positive rate against the false positive rate as we
vary the threshold used by the classifier. AUC refers sim-
ply to the area under this curve; 1.0 is a perfect score and
0.5 is equivalent to a random ordering. The work saved
over random sampling measured at 0.95 recall (WSS@95),
introduced in [16], refers to the percentage of studies that
the reviewers do not have to go through because they have
been screened out by the classifier at a recall of 0.95, com-
pared to random sampling. WSS =
TN+FN
N
(1 Recall)
where TN is the number of true negatives, FN is the
number of false negatives, and N is the total number of
instances in the dataset. Recall refers to the recall of the
positive class (included studies). The results we obtained
are AUC = 0.87 ± 0.09 and WSS@95 = 0.49 ± 0.18.
The 49% result is important since it shows that Rayyan
can help save time using the automatic prediction. While

Citations
More filters
Journal ArticleDOI
TL;DR: The effectiveness of a range of interventions that include diet or physical activity components, or both, designed to prevent obesity in children is evaluated to determine overall certainty of the evidence.
Abstract: The current evidence suggests that many diet and exercise interventions to prevent obesity in children are not effective in preventing weight gain, but can be effective in promoting a healthy diet and increased physical activity levels.Being very overweight (obese) can cause health, psychological and social problems for children. Children who are obese are more likely to have weight and health problems as adults. Programmes designed to prevent obesity focus on modifying one or more of the factors considered to promote obesity.This review included 22 studies that tested a variety of intervention programmes, which involved increased physical activity and dietary changes, singly or in combination. Participants were under 18 and living in Asia, South America, Europe or North America. There is not enough evidence from trials to prove that any one particular programme can prevent obesity in children, although comprehensive strategies to address dietary and physical activity change, together with psycho-social support and environmental change may help. There was a trend for newer interventions to involve their respective communities and to include evaluations.Future research might usefully assess changes made on behalf of entire populations, such as improvements in the types of foods available at schools and in the availability of safe places to run and play, and should assess health effects and costs over several years.The programmes in this review used different strategies to prevent obesity so direct comparisons were difficult. Also, the duration of the studies ranged from 12 weeks to three years, but most lasted less than a year.

2,464 citations

Journal ArticleDOI
TL;DR: Patients and surgeons can expect a hip replacement to last 25 years in around 58% of patients, assuming that estimates from national registries are less likely to be biased.

516 citations

Journal ArticleDOI
TL;DR: A systematic review and random‐effects meta‐analysis to assess the prevalence of depression, anxiety, and sleep disturbances in COVID‐19 patients found no significant differences in the prevalence estimates between different genders; however, the depression and anxiety prevalence estimates varied based on different screening tools.
Abstract: Evidence from previous coronavirus outbreaks has shown that infected patients are at risk for developing psychiatric and mental health disorders, such as depression, anxiety, and sleep disturbances. To construct a comprehensive picture of the mental health status in COVID-19 patients, we conducted a systematic review and random-effects meta-analysis to assess the prevalence of depression, anxiety, and sleep disturbances in this population. We searched MEDLINE, EMBASE, PubMed, Web of Science, CINAHL, Wanfang Data, Wangfang Med Online, CNKI, and CQVIP for relevant articles, and we included 31 studies (n = 5153) in our analyses. We found that the pooled prevalence of depression was 45% (95% CI: 37-54%, I2 = 96%), the pooled prevalence of anxiety was 47% (95% CI: 37-57%, I2 = 97%), and the pooled prevalence of sleeping disturbances was 34% (95% CI: 19-50%, I2 = 98%). We did not find any significant differences in the prevalence estimates between different genders; however, the depression and anxiety prevalence estimates varied based on different screening tools. More observational studies assessing the mental wellness of COVID-19 outpatients and COVID-19 patients from countries other than China are needed to further examine the psychological implications of COVID-19 infections.

425 citations

Journal ArticleDOI
TL;DR: This umbrella review found severe mental health problems among individuals and populations who have undergone quarantine and isolation in different contexts and necessitates multipronged interventions including policy measures for strengthening mental health services globally and promoting psychosocial wellbeing among high-risk populations.
Abstract: Objectives Transmission of infectious diseases is often prevented by quarantine and isolation of the populations at risk. These approaches restrict the mobility, social interactions, and daily activities of the affected individuals. In recent coronavirus disease 2019 (COVID-19) pandemic, quarantine and isolation are being adopted in many contexts, which necessitates an evaluation of global evidence on how such measures impact the mental health outcomes among populations. This umbrella review aimed to synthesize the available evidence on mental health outcomes of quarantine and isolation for preventing infectious diseases. Methods We searched nine major databases and additional sources and included articles if they were systematically conducted reviews, published as peer-reviewed journal articles, and reported mental health outcomes of quarantine or isolation in any population. Results Among 1,364 citations, only eight reviews met our criteria. Most of the primary studies in those reviews were conducted in high-income nations and in hospital settings. These articles reported a high burden of mental health problems among patients, informal caregivers, and healthcare providers who experienced quarantine or isolation. Prevalent mental health problems among the affected individuals include depression, anxiety, mood disorders, psychological distress, posttraumatic stress disorder, insomnia, fear, stigmatization, low self-esteem, lack of self-control, and other adverse mental health outcomes. Conclusions This umbrella review found severe mental health problems among individuals and populations who have undergone quarantine and isolation in different contexts. This evidence necessitates multipronged interventions including policy measures for strengthening mental health services globally and promoting psychosocial wellbeing among high-risk populations.

374 citations

Journal ArticleDOI
TL;DR: In this article, a living systematic review was conducted to synthesize evidence on Long Covid characteristics, to inform clinical management, rehabilitation, and interventional studies to improve long term outcomes.
Abstract: Background: While it is now apparent clinical sequelae (often called Long Covid) may persist after acute Covid-19, their nature, frequency, and aetiology are poorly characterised. This study aims to regularly synthesise evidence on Long Covid characteristics, to inform clinical management, rehabilitation, and interventional studies to improve long term outcomes. Methods: A living systematic review. Medline, CINAHL (EBSCO), Global Health (Ovid), WHO Global Research Database on Covid-19, LitCOVID, and Google Scholar were searched up to 17th March 2021. Published studies including at least 100 people with confirmed or clinically suspected Covid-19 at 12 weeks or more post-onset were included. Results were analysed using descriptive statistics and meta-analyses to estimate prevalence with 95% confidence intervals (CIs). Results: Thirty-nine studies were included: 32 cohort, six cross-sectional, and one case-control. Most showed high or moderate risk of bias. None were set in low-income countries, limited studies included children. Studies reported on 10,951 people (48% female) in 12 countries. Most followed-up post hospital discharge (78%, 8520/10951). The longest mean follow-up was 221.7 (SD: 10.9) days post Covid-19 onset. An extensive range of symptoms with wide prevalence was reported, most commonly weakness (41%; 95% CI 25% to 59%), malaise (33%; 95% CI 15% to 57%), fatigue (31%; 95% CI 24% to 39%), concentration impairment (26%; 95% CI 21% to 32%), and breathlessness (25%; 95% CI 18% to 34%). Other frequent symptoms included musculoskeletal, neurological, and psychological. 37% (95% CI 18% to 60%) of people reported reduced quality of life. Conclusion: Long Covid is a complex condition with heterogeneous symptoms. The nature of the studies precludes a precise case definition or evaluation of risk factors. There is an urgent need for prospective, robust, standardised controlled studies into aetiology, risk factors, and biomarkers to characterise Long Covid in different at-risk populations and settings. Systematic review registration: The protocol was prospectively registered on the PROSPERO database (CRD42020211131).

352 citations

References
More filters
Journal ArticleDOI
TL;DR: Moher et al. as mentioned in this paper introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses, which is used in this paper.
Abstract: David Moher and colleagues introduce PRISMA, an update of the QUOROM guidelines for reporting systematic reviews and meta-analyses

62,157 citations

Journal Article
TL;DR: The QUOROM Statement (QUality Of Reporting Of Meta-analyses) as mentioned in this paper was developed to address the suboptimal reporting of systematic reviews and meta-analysis of randomized controlled trials.
Abstract: Systematic reviews and meta-analyses have become increasingly important in health care. Clinicians read them to keep up to date with their field,1,2 and they are often used as a starting point for developing clinical practice guidelines. Granting agencies may require a systematic review to ensure there is justification for further research,3 and some health care journals are moving in this direction.4 As with all research, the value of a systematic review depends on what was done, what was found, and the clarity of reporting. As with other publications, the reporting quality of systematic reviews varies, limiting readers' ability to assess the strengths and weaknesses of those reviews. Several early studies evaluated the quality of review reports. In 1987, Mulrow examined 50 review articles published in 4 leading medical journals in 1985 and 1986 and found that none met all 8 explicit scientific criteria, such as a quality assessment of included studies.5 In 1987, Sacks and colleagues6 evaluated the adequacy of reporting of 83 meta-analyses on 23 characteristics in 6 domains. Reporting was generally poor; between 1 and 14 characteristics were adequately reported (mean = 7.7; standard deviation = 2.7). A 1996 update of this study found little improvement.7 In 1996, to address the suboptimal reporting of meta-analyses, an international group developed a guidance called the QUOROM Statement (QUality Of Reporting Of Meta-analyses), which focused on the reporting of meta-analyses of randomized controlled trials.8 In this article, we summarize a revision of these guidelines, renamed PRISMA (Preferred Reporting Items for Systematic reviews and Meta-Analyses), which have been updated to address several conceptual and practical advances in the science of systematic reviews (Box 1). Box 1 Conceptual issues in the evolution from QUOROM to PRISMA

46,935 citations

Journal ArticleDOI
TL;DR: High generalization ability of support-vector networks utilizing polynomial input transformations is demonstrated and the performance of the support- vector network is compared to various classical learning algorithms that all took part in a benchmark study of Optical Character Recognition.
Abstract: The support-vector network is a new learning machine for two-group classification problems. The machine conceptually implements the following idea: input vectors are non-linearly mapped to a very high-dimension feature space. In this feature space a linear decision surface is constructed. Special properties of the decision surface ensures high generalization ability of the learning machine. The idea behind the support-vector network was previously implemented for the restricted case where the training data can be separated without errors. We here extend this result to non-separable training data. High generalization ability of support-vector networks utilizing polynomial input transformations is demonstrated. We also compare the performance of the support-vector network to various classical learning algorithms that all took part in a benchmark study of Optical Character Recognition.

37,861 citations

Journal ArticleDOI
TL;DR: A structured summary is provided including, as applicable, background, objectives, data sources, study eligibility criteria, participants, interventions, study appraisal and synthesis methods, results, limitations, conclusions and implications of key findings.

31,379 citations


"Rayyan-a web and mobile app for sys..." refers background in this paper

  • ...In addition, the tracking of decisions to include or exclude studies and the reporting of these judgments in a PRISMA flow diagram is mandatory for all Cochrane reviews and is now being done increasingly in other systematic reviews as this becomes a more widely accepted prerequisite for manuscript publication [3]....

    [...]

Journal ArticleDOI
TL;DR: A reasonable standard design and conduct of trials will facilitate the interpretation of those with conflicting results and help in making valid combinations of undersized trials.

1,364 citations


"Rayyan-a web and mobile app for sys..." refers background in this paper

  • ...Background Randomized controlled trials (RCTs) play a pivotal role in medical research and are widely considered to be the best way of achieving results that can genuinely increase our knowledge about treatment effectiveness [1]....

    [...]

Trending Questions (1)
How to scrren articles in Rayyan?

Rayyan expedites article screening through semi-automation, enhancing usability. Users reported 40% average time savings, with screening and collaboration highlighted as key features.